Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 TOOKAD VTP for low-grade upper tract urothelial carcinoma
MOH_2021-09-29_010271Phase 3Recruiting
- Sponsor
- Steba Biotech
- Start
- Aug 2021
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of padeliporfin VTP in upper tract urothelial carcinoma (UTUC), sponsored by Steba Biotech. Started Aug 2021; status: recruiting.
02
Drugs
padeliporfin VTP
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on MOH_2021-09-29_010271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-09-29_010271.